| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |